Mumbai,
Aug 31: Pharma Major, Ajanta Pharma has launched Eletriptan Hydrobromide
Tablets in the US market through its wholly owned subsidiary Ajanta Pharma USA.
It is a bioequivalent generic version of Relpax Tablets. The company has
launched the product in two strengths, 20 mg and 40 mg tablets. Eletriptan
Hydrobromide Tablets is part of an ever growing portfolio of products that
Ajanta has developed for the US market. In total, Ajanta has 35 Abbreviated New
Drug Applications (ANDAs) of which it has 19 final ANDA approvals, 2 tentative
approvals, and 14 ANDAs under review with US FDA. So far it has launched 14
products in the US market. UNI
Subscribe to:
Post Comments (Atom)
Post A Comment:
0 comments so far,add yours